Figure 6 | Scientific Reports

Figure 6

From: Thrombin@Fe3O4 nanoparticles for use as a hemostatic agent in internal bleeding

Figure 6

Time (a) and mass of blood (b) flowed out of the model blood vessel during an experiment on analyzing hemostatic activity. The measurements were carried out with different amounts of fibrinogen. The administration of hemostatic nanoparticles is shown to significantly reduce the time and mass of blood prior to hemostasis compared to the control, especially when an external magnetic field is applied and the nanoparticles are concentrated accordingly.

Back to article page